Formidable Asset Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Formidable Asset Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$58K	–	331
2023 Q1	$58K	Hold	200	–	–	0.01%	296
2022 Q4	$52K	Buy	+200	New	+$53.7K	0.01%	301
2022 Q2	–	Sell	-200	Closed	-$122K	–	357
2022 Q1	$122K	Buy	+200	New	+$111K	0.02%	318

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Formidable Asset Management's APTO Position: Q2 2023 in Review

Formidable Asset Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 200 shares — an estimated $58K sold.

Formidable Asset Management first reported a position in APTO in Q1 2022 and held it in 3 quarters. The position peaked at $122K in Q1 2022. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

Formidable Asset Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
Formidable Asset Management sold 200 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $58K.
Formidable Asset Management first reported a position in Aptose Biosciences, Inc. in Q1 2022 and held it in 3 quarters.
Formidable Asset Management's Aptose Biosciences, Inc. position peaked at $122K in Q1 2022.
24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Formidable Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.